Abstract
Intraperitoneal (IP) insulin treatment has been proposed as an alternative approach to conventional subcutaneous (SC) insulin therapy. The rationale for doing that is in the partial portal insulin absorption producing more physiologic plasma insulin kinetics. Both external and implantable devices have been used for IP insulin administration. This study analyzed the clinical feasibility and therapeutic efficacy of a chronic IP insulin treatment by means of an implantable constant rate insulin infusion pump.
| Original language | English |
|---|---|
| Pages (from-to) | 1687-1688 |
| Number of pages | 2 |
| Journal | Transplantation Proceedings |
| Volume | 18 |
| Issue number | 6 |
| Publication status | Published - 1986 |
ASJC Scopus subject areas
- Surgery
- Transplantation
Fingerprint Dive into the research topics of 'Implantable devices for constant rate intraperitoneal insulin administration: 1 year follow-up'. Together they form a unique fingerprint.
Cite this
Librenti, M. C., Monti, L. D., & Galimberti, G. (1986). Implantable devices for constant rate intraperitoneal insulin administration: 1 year follow-up. Transplantation Proceedings, 18(6), 1687-1688.